You are here
This trial is looking at volrustomig (MEDI5752) for head and neck cancer that has spread into the surrounding tissue and cannot be removed by surgery.
This study is looking at using an app to see if it can help support people having treatment for head and neck cancer.
This trial is looking at PET-CT guided patient led follow up.
This study is looking at a drug called INCB106385 by itself or with another immunotherapy called retifanlimab (INCMGA00012) for some advanced solid cancers.
This trial is looking at whether a programme of exercises before treatment can help people with their eating, drinking and swallowing after treatment.
This trial is looking at adding certain targeted drugs to radiotherapy for head and neck cancer.
This trial is looking at adding monalizumab to cetuximab for people who have squamous cell cancer of the head and neck.
This trial is comparing lenvatinib and pembrolizumab with standard treatment for cancer of the head and neck.
This study is adjusting the plan of radiotherapy during treatment. This is to target the cancer better and to have less treatment go to the surrounding organs.
This study is looking at whether vitamin E and pentoxifylline can prevent tissue damage and a jaw problem called osteoradionecrosis.
